Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Heart transplants: need versus availability.

M Salik Jahania1, Robert M Mentzer

  • 1Division of Cardiothoracic Surgery, Department of Surgery, University of Kentucky College of Medicine, Lexington, Kentucky, USA. sjahani@uky.edu

The Journal of the Kentucky Medical Association
|March 26, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Enhanced Parkin-mediated mitophagy mitigates adverse left ventricular remodelling after myocardial infarction: role of PR-364.

European heart journal·2024
Same author

Asporin, an extracellular matrix protein, is a beneficial regulator of cardiac remodeling.

Matrix biology : journal of the International Society for Matrix Biology·2022
Same author

Attenuation of Adverse Postinfarction Left Ventricular Remodeling with Empagliflozin Enhances Mitochondria-Linked Cellular Energetics and Mitochondrial Biogenesis.

International journal of molecular sciences·2022
Same author

Proteomics of Mouse Heart Ventricles Reveals Mitochondria and Metabolism as Major Targets of a Post-Infarction Short-Acting GLP1Ra-Therapy.

International journal of molecular sciences·2021
Same author

Intermittent Use of a Short-Course Glucagon-like Peptide-1 Receptor Agonist Therapy Limits Adverse Cardiac Remodeling via Parkin-dependent Mitochondrial Turnover.

Scientific reports·2020
Same author

Myocardial hypothermia increases autophagic flux, mitochondrial mass and myocardial function after ischemia-reperfusion injury.

Scientific reports·2019
Same journal

Distractive driving or sharks... you be the judge.

The Journal of the Kentucky Medical Association·2010
Same journal

Parental perception of children's weight as a function of ethnicity/race, gender, and age.

The Journal of the Kentucky Medical Association·2010
Same journal

Spurious hypoxemia.

The Journal of the Kentucky Medical Association·2010
Same journal

Funding for a healthy future in Kentucky.

The Journal of the Kentucky Medical Association·2010
Same journal

H1N1.

The Journal of the Kentucky Medical Association·2010
Same journal

The safety and price of guns in Kentucky.

The Journal of the Kentucky Medical Association·2010
See all related articles

Heart failure causes significant deaths and economic burden in the US. Advances in vascular anastomosis, cardiopulmonary bypass, and transplantation techniques have improved treatment, but immunosuppression remains key for long-term survival.

Area of Science:

  • Cardiovascular Medicine
  • Surgical Innovation
  • Transplantation Immunology

Background:

  • Heart failure is a leading cause of death in the US, with high mortality and significant economic impact.
  • Advanced heart failure survival rates are below 50% within two years.
  • The economic burden of heart failure is substantial, costing billions annually.

Purpose of the Study:

  • To review the historical advancements in heart failure treatment.
  • To highlight key pioneers and their contributions to cardiovascular surgery and transplantation.
  • To underscore the importance of immunosuppressive techniques in improving long-term transplant outcomes.

Main Methods:

  • Historical review of significant contributions to heart failure treatment.

Related Experiment Videos

  • Examination of pioneering work in vascular anastomosis and cardiopulmonary bypass.
  • Analysis of early heart transplant procedures and xenotransplantation attempts.

    • Main Results:

    • Early surgical innovations like vascular anastomosis and cardiopulmonary bypass laid groundwork for advanced treatments.
    • Pioneering heart transplant procedures in animal models and humans demonstrated feasibility.
    • Initial human transplants showed limited long-term survival, necessitating further research.

    Conclusions:

    • The evolution of heart failure treatment is marked by significant surgical and technological milestones.
    • Key figures like Carrel, Gibbon, Shumway, and Barnard were instrumental in advancing cardiovascular interventions.
    • Progress in immunosuppressive therapies is critical for improving long-term survival in heart transplant recipients.